Latest News about STSA
Recent news which mentions STSA
12 Health Care Stocks Moving In Monday's Pre-Market Session
November 14, 2022
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
October 12, 2022
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
October 10, 2022
From Benzinga
Why Applied DNA Sciences Shares Are Trading Higher By Around 65%, Here Are 54 Stocks Moving In Monday's Mid-Day Session
October 10, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2022
October 10, 2022
From Benzinga
This Analyst Boosts Price Target On Satsuma Pharmaceuticals By 200%? Plus UBS Predicts $38 For General Motors
October 10, 2022
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
September 20, 2022
From Benzinga
Satsuma Pharma Shares Are Gaining After Encouraging Update From Migraine Candidate
September 20, 2022
Tickers
STSA
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 31, 2022
August 31, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022
August 25, 2022
From Benzinga
From Benzinga
Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary
August 02, 2022
From Benzinga
From Benzinga
5 Biotech Stocks To Watch During The Week Of June 13
June 13, 2022
From Benzinga
Mizuho Remains Bullish On This Small-Cap Stock's Migraine Candidate, But Why Did It Cut Price Target
May 13, 2022
From Benzinga
From Benzinga
The Week Ahead In Biotech (April 3-April 9): BioXcel FDA Decision, Neurology Conference Presentations Take The Spotlight
April 03, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Friday
April 01, 2022
From Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
March 09, 2022
From Benzinga
3 Stocks Insiders Are Buying
October 22, 2021
From Benzinga
The Daily Biotech Pulse: Novavax Retreats Amid Vaccine Issues, LumiraDx COVID Test Approved In India, Sesen Shines On Positive Bladder Cancer Review
October 20, 2021
From Benzinga
40 Biggest Movers From Yesterday
October 07, 2021
From Benzinga
The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs
July 29, 2021
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.